Matrix Metalloproteinases 2 and 9 and their Tissue Inhibitors in the Follicular Fluid of Patients with Polycystic Ovaries Undergoing In Vitro Fertilisation

被引：3

作者：

Baka, Stavroula ^{[1
,2
]}

Zourla, Konstantina ^{[1
]}

Kouskouni, Evangelia ^{[1
]}

Makrakis, Evangelos ^{[3
]}

Demeridou, Stella ^{[1
]}

Tzanakaki, Despoina ^{[2
]}

Hassiakos, Dimitris ^{[2
]}

Creatsas, George ^{[2
]}

机构：

[1] Univ Athens, Aretaie Hosp, Dept Biopathol, GR-10679 Athens, Greece

[2] Univ Athens, Aretaie Hosp, Dept Assisted Reprod Unit, Dept Obstet & Gynecol 2, GR-10679 Athens, Greece

[3] Embryo ART, IVF Unit, Athens, Greece

来源：

IN VIVO | 2010年 / 24卷 / 03期

关键词：

Matrix metalloproteinases; tissue inhibitors of matrix metalloproteinases; follicular fluid; polycystic ovary syndrome; in vitro fertilisation; LUTEINIZED GRANULOSA-CELLS; WOMEN; EXPRESSION; MATRIX-METALLOPROTEINASE-9; AND-9;

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The present study was undertaken to investigate the levels of matrix metalloproteinase (MMP)-2, MMP-9 and their tissue inhibitors (TIMP-2 and TIMP-1, respectively) in the follicular fluid of 39 patients with polycystic ovary syndrome (PCOS) and compare them with the levels found in 56 age- and weight-matched normally ovulating women, all undergoing in vitro fertilisation (IVF) treatment. Significantly higher levels of MMP-2 and MMP-9 (p=0.02 and p<0.001, respectively) as well as TIMP-2 and TIMP-1 (p=0.006 and p<0.001, respectively) were found in the PCOS group compared to controls. Women who achieved pregnancy had higher TIMP-1 levels compared to the non-pregnant ones in the control group (p=0.01). In conclusion, women with PCOS exhibited significantly increased gelatinolytic activity compared with controls of similar age and body mass index, thus indicating a more intense extracellular matrix remodelling in this group of patients during IVF treatment due to multiple follicular development and cyst formation.

引用

页码：291 / 294

页数：4

共 16 条

[11] Gelatinases and their tissue inhibitors during human ovulation:: increased expression of tissue inhibitor of matrix metalloproteinase-1 [J].

Lind, A. -K. ;

Dahm-Kahler, P. ;

Weijdegard, B. ;

Sundfeldt, K. ;

Brannstrom, M. .

MOLECULAR HUMAN REPRODUCTION, 2006, 12 (12) :725-736

[12]

Nikolettos N, 2003, IN VIVO, V17, P201

[13] Secretion of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases into follicular fluid during follicle development in equine ovaries [J].

Riley, SC ;

Gibson, AH ;

Leask, R ;

Mauchline, DJW ;

Pedersen, HG ;

Watson, ED .

REPRODUCTION, 2001, 121 (04) :553-560

[14] The balance between MMP-9 and MMP-2 and their tissue inhibitor (TIMP)-1 in luteinized granulosa cells: comparison between women with PCOS and normal ovulatory women [J].

Shalev, E ;

Goldman, S ;

Ben-Shlomo, I .

MOLECULAR HUMAN REPRODUCTION, 2001, 7 (04) :325-331

[15] Serum matrix metalloproteinase and tissue inhibitor of metalloproteinase concentrations in infertile women achieved pregnancy following IVF-ET [J].

Shibahara, H ;

Suzuki, T ;

Kikuchi, K ;

Hirano, Y ;

Suzuki, M .

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2005, 54 (04) :186-192

[16]

Stamouli A, 1996, J REPROD FERTIL, V107, P235

← 1 2 →